Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients.

NCT04700709 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Sirolimus Tab.
DRUG: Mycophenolate Mofetil Cap./Tab.

Sponsor

Chong Kun Dang Pharmaceutical